本レポートは、戦略担当者、マーケティング担当者、経営幹部に、世界の経口生物製剤（バイオ医薬品）・バイオシミラー医薬品市場を評価するために必要な重要な情報を提供します。
また、力強い成長を遂げている経口生物製剤・バイオシミラー医薬品市場に焦点を当てています。本レポートは、世界的なパンデミックという課題に対する市場の対応など、今後10年以上にわたって私たちの生活を形作り変化させる経口生物製剤・バイオシミラー医薬品市場へのガイドを提供します。
目次
Table of Contents
1. Executive Summary
2. Oral Biologics & Biosimilars Market Characteristics
3. Oral Biologics & Biosimilars Market Trends And Strategies
4. Impact Of COVID-19 On Oral Biologics & Biosimilars
5. Oral Biologics & Biosimilars Market Size And Growth
5.1. Global Oral Biologics & Biosimilars Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Oral Biologics & Biosimilars Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Oral Biologics & Biosimilars Market Segmentation
6.1. Global Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Lymphocyte Modulators
Interleukin Inhibitors
Tumor Necrosis Factor-Alpha Inhibitors
6.2. Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Asthma
Crohn'S Disease
Carcinoma
Arthritis
Diabetes
Multiple Myeloma
Enterocolitis
Multiple Sclerosis
Sarcoma
Psoriasis and Others
6.3. Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Vaccines
Proteins & Peptides
Monoclonal Antibodies
Others
6.4. Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
7. Oral Biologics & Biosimilars Market Regional And Country Analysis
7.1. Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Oral Biologics & Biosimilars Market
8.1. Asia-Pacific Oral Biologics & Biosimilars Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Oral Biologics & Biosimilars Market
9.1. China Oral Biologics & Biosimilars Market Overview
9.2. China Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Oral Biologics & Biosimilars Market
10.1. India Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Oral Biologics & Biosimilars Market
11.1. Japan Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Oral Biologics & Biosimilars Market
12.1. Australia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Oral Biologics & Biosimilars Market
13.1. Indonesia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Oral Biologics & Biosimilars Market
14.1. South Korea Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Oral Biologics & Biosimilars Market
15.1. Western Europe Oral Biologics & Biosimilars Market Overview
15.2. Western Europe Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Oral Biologics & Biosimilars Market
16.1. UK Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Oral Biologics & Biosimilars Market
17.1. Germany Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Oral Biologics & Biosimilars Market
18.3. France Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Oral Biologics & Biosimilars Market
19.1. Eastern Europe Oral Biologics & Biosimilars Market Overview
19.2. Eastern Europe Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Oral Biologics & Biosimilars Market
20.1. Russia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Oral Biologics & Biosimilars Market
21.1. North America Oral Biologics & Biosimilars Market Overview
21.2. North America Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Oral Biologics & Biosimilars Market
22.1. USA Oral Biologics & Biosimilars Market Overview
22.2. USA Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Oral Biologics & Biosimilars Market
23.1. South America Oral Biologics & Biosimilars Market Overview
23.2. South America Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Oral Biologics & Biosimilars Market
24.1. Brazil Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Oral Biologics & Biosimilars Market
25.1. Middle East Oral Biologics & Biosimilars Market Overview
25.2. Middle East Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Oral Biologics & Biosimilars Market
26.1. Africa Oral Biologics & Biosimilars Market Overview
26.2. Africa Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Oral Biologics & Biosimilars Market Competitive Landscape And Company Profiles
27.1. Oral Biologics & Biosimilars Market Competitive Landscape
27.2. Oral Biologics & Biosimilars Market Company Profiles
27.2.1. Novartis
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Rani Therapeutics
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Eli Lilly and Co.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. AstraZeneca plc
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Novo Nordisk A/S
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Oral Biologics & Biosimilars Pipeline Analysis
29. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market
30. Oral Biologics & Biosimilars Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer
List of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 6: Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: China, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: India, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: Japan, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 13: Australia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 14: Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 15: South Korea, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 16: Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 17: UK, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 18: Germany, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 19: France, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 20: Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 21: Russia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 22: North America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 23: USA, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 24: South America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 25: Brazil, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 26: Middle East, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 27: Africa, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 28: Novartis Financial Performance
Table 29: Rani Therapeutics Financial Performance
Table 30: Eli Lilly and Co. Financial Performance
Table 31: AstraZeneca plc Financial Performance
Table 32: Novo Nordisk A/S Financial Performance
List of Figures
Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Figure 3: Global Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 4: Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 5: Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 6: Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: China, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: India, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: Japan, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 13: Australia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 14: Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 15: South Korea, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 16: Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 17: UK, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 18: Germany, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 19: France, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 20: Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 21: Russia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 22: North America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 23: USA, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 24: South America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 25: Brazil, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 26: Middle East, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 27: Africa, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 28: Novartis Financial Performance
Figure 29: Rani Therapeutics Financial Performance
Figure 30: Eli Lilly and Co. Financial Performance
Figure 31: AstraZeneca plc Financial Performance
Figure 32: Novo Nordisk A/S Financial Performance
